A semi-synthetic organism that stores and retrieves increased genetic information
A semi-synthetic organism that stores and retrieves increased genetic information
批准号:
9469534
负责人:
Floyd E. Romesberg
金额:
$72.21万
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-05-01 至 2021-04-30
关键词:
Amino AcidsBase PairingCellsClustered Regularly Interspaced Short Palindromic RepeatsCodon NucleotidesDNADevelopmentEngineeringEscherichia coliEvolutionFoundationsFundingGenesGeneticGenetic TranscriptionGenomeGenomicsHealthHumanHydrogen BondingHydrophobicityInstructionLettersLifeMediatingMedicineMessenger RNANucleotidesOrganismProductionProteinsRNATherapeuticTransfer RNATriplet Multiple BirthUnited States National Institutes of HealthWorkbasegenetic informationhydrophilicityimprovednovelnucleasepromoterpublic health relevancetherapeutic proteintranslational approachtripolyphosphateunnatural amino acidsuptake
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Organisms are defined by the information encoded in their genomes, and since the evolution of life as we know it, this information has been encoded using a four-letter genetic alphabet, made possible by the selective pairing of (d)G with (d)C and (d)A with dT or U. The creation of a third, unnatural base pair (UBP) would have profound implications for our understanding of what life is and how it may have evolved, and could serve as the foundation of a semi-synthetic organism (SSO), a living cell that stores information beyond that of the natural genetic alphabet and retrieves it in the form of proteins containing unnatural amino acids. This has great potential to improve human health, as proteins now constitute an important class of therapeutics, but their utility is currently restricted by the limted physicochemical diversity of the twenty natural amino acids. Since 1999, our NIH-funded work has focused on the development of a UBP. Our strategy is based on the use of hydrophobic and packing forces, as opposed to Watson-Crick-like hydrogen bonds, to optimize UBP formation, as we have found that such forces are strong and disfavor mispairing with the natural, more hydrophilic nucleotides. This effort reached major milestones in 2009 with our discovery of the UBP formed between dNaM and d5SICS, and in 2014 with our engineering of an E. coli-based SSO that stably harbors this UBP in its DNA. In the past year, we have continued to optimize the SSO, including the optimization and genomic integration of the gene encoding the nucleotide triphosphate transporter from Phaeodactylum tricornutum (PtNTT2), which makes import of dNaMTP and d5SICSTP into the cell possible. With the optimized PtNTT2 now under the control of a constitutive promoter, the SSO is more healthy and always competent for unnatural triphosphate uptake. While we have discovered that replication of the UBP proceeds with a sequence bias, we have already made progress towards eliminating the bias by continuing to optimize the UBP, and by introducing an error-correction mechanism mediated by CRISPR-associated protein-9 nuclease (Cas9). We have also demonstrated that DNA containing the UBP may be transcribed within the SSO into RNA containing unnatural nucleotides. Although continued exploration and optimization is still required, the major challenges of creating the first form of life that stably harbors and retrieves information beyond that encoded by the natural genetic alphabet have been identified. These include the optimization of replication to eliminate the observed sequence bias, the optimization of transcription, including the transcription of mRNAs and tRNAs, and lastly, the demonstration of efficient translation, and strategies toward overcoming these challenges are described. If successful, our efforts will yield the first form of life that faithfully stores and retrieves infomation beyond that encoded by the natural genetic alphabet, and will result in a general platform for the production of diverse, therapeutic proteins that could revolutionize medicine.
期刊论文(8)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1016/j.cbpa.2018.08.009
发表时间:
2018-10
期刊:
Current opinion in chemical biology
影响因子:
7.8
作者:
[Dien VT, Morris SE, Karadeema RJ, Romesberg FE]
通讯作者:
Romesberg FE
DOI:
10.1021/jacs.9b09080
发表时间:
2019-12
期刊:
Journal of the American Chemical Society
影响因子:
15
作者:
[Anne Xiao-Zhou Zhou-Anne-Xiao-Zhou-Zhou-13769862;Kai Sheng;Aaron W Feldman;F. Romesberg]
通讯作者:
Anne Xiao-Zhou Zhou-Anne-Xiao-Zhou-Zhou-13769862;Kai Sheng;Aaron W Feldman;F. Romesberg
DOI:
10.1021/jacs.7b11404
发表时间:
2018-01-31
期刊:
Journal of the American Chemical Society
影响因子:
15
作者:
[Feldman AW, Fischer EC, Ledbetter MP, Liao JY, Chaput JC, Romesberg FE]
通讯作者:
Romesberg FE
Increasing the Utility of Polymerases by Directed Evolution
-
批准号:8658106
-
项目类别:
-
资助金额:$36.01万
-
财政年份:2011
-
负责人:Floyd E. Romesberg
-
依托单位:
Developing a Novel Plague Antibiotic by Targeting Protein Secretion
-
批准号:8032085
-
项目类别:
-
资助金额:$26.48万
-
财政年份:2011
-
负责人:Floyd E. Romesberg
-
依托单位:
Increasing the Utility of Polymerases by Directed Evolution
-
批准号:8086251
-
项目类别:
-
资助金额:$32.6万
-
财政年份:2011
-
负责人:Floyd E. Romesberg
-
依托单位:
Increasing the Utility of Polymerases by Directed Evolution
-
批准号:8320234
-
项目类别:
-
资助金额:$36.01万
-
财政年份:2011
-
负责人:Floyd E. Romesberg
-
依托单位:
Developing a Novel Plague Antibiotic by Targeting Protein Secretion
-
批准号:8209017
-
项目类别:
-
资助金额:$23.69万
-
财政年份:2011
-
负责人:Floyd E. Romesberg
-
依托单位:
Increasing the Utility of Polymerases by Directed Evolution
-
批准号:8470663
-
项目类别:
-
资助金额:$34.74万
-
财政年份:2011
-
负责人:Floyd E. Romesberg
-
依托单位:
The Contribution of Protein Dynamics to Antibody Affinity Maturation
-
批准号:7924383
-
项目类别:
-
资助金额:$43.35万
-
财政年份:2009
-
负责人:Floyd E. Romesberg
-
依托单位:
Re-engineering the arylomycins for antibiotic activity
-
批准号:7895579
-
项目类别:
-
资助金额:$23.74万
-
财政年份:2009
-
负责人:Floyd E. Romesberg
-
依托单位:
Re-engineering the arylomycins for antibiotic activity
-
批准号:7740309
-
项目类别:
-
资助金额:$25.79万
-
财政年份:2009
-
负责人:Floyd E. Romesberg
-
依托单位:
INHIBITION OF SIGNAL PEPTIDASE DEPENDENT SECRETED PROTEINS BY ARYLOMYCIN
-
批准号:7957718
-
项目类别:
-
资助金额:$0.33万
-
财政年份:2009
-
负责人:Floyd E. Romesberg
-
依托单位:
Evolving Novel Polymerases for Genome Sequencing
-
批准号:7077919
-
项目类别:
-
资助金额:$27.89万
-
财政年份:2006
-
负责人:Floyd E. Romesberg
-
依托单位:
Evolving Novel Polymerases for Genome Sequencing
-
批准号:7244085
-
项目类别:
-
资助金额:$22.56万
-
财政年份:2006
-
负责人:Floyd E. Romesberg
-
依托单位:
RAD6 MEDIATED POST-REPLICATION AND REPAIR MUTAGENESIS PATHWAY
-
批准号:7182377
-
项目类别:
-
资助金额:$0.4万
-
财政年份:2005
-
负责人:Floyd E. Romesberg
-
依托单位:
Pathways Controlling Genome Stability and Mutation
-
批准号:6866572
-
项目类别:
-
资助金额:$35.44万
-
财政年份:2004
-
负责人:Floyd E. Romesberg
-
依托单位:
Pathways Controlling Genome Stability and Mutation
-
批准号:6774578
-
项目类别:
-
资助金额:$34.75万
-
财政年份:2004
-
负责人:Floyd E. Romesberg
-
依托单位:
MODELING FLEXIBILITY & DYNAMICAL MOTION IN COMPLEX PROTEIN SYSTEMS
-
批准号:6975441
-
项目类别:
-
资助金额:$2.01万
-
财政年份:2004
-
负责人:Floyd E. Romesberg
-
依托单位:
Pathways Controlling Genome Stability and Mutation
-
批准号:7215602
-
项目类别:
-
资助金额:$34.7万
-
财政年份:2004
-
负责人:Floyd E. Romesberg
-
依托单位:
Pathways Controlling Genome Stability and Mutation
-
批准号:7036507
-
项目类别:
-
资助金额:$35.74万
-
财政年份:2004
-
负责人:Floyd E. Romesberg
-
依托单位:
Expanding the Genetic Alphabet by Design and Selection
-
批准号:7029732
-
项目类别:
-
资助金额:$34.49万
-
财政年份:1999
-
负责人:Floyd E. Romesberg
-
依托单位:
Expanding the Genetic Alphabet by Design and Selection
-
批准号:7895546
-
项目类别:
-
资助金额:$39.85万
-
财政年份:1999
-
负责人:Floyd E. Romesberg
-
依托单位:
海外基金